Calgenex Corporation Introduces New Topical Psoriasis Treatment
9/27/2006 12:35:16 PM
TAMPA, Fla.--(BUSINESS WIRE)--Calgenex Corporation today announced the introduction of Dermalleve, a new over-the-counter (OTC) topical drug treatment for psoriasis, eczema, and seborrheic dermatitis. Dermalleve combines maximum-strength anti-pruritic medicine with natural skin conditioners and emollients to stop the itching, reduce inflammation, and support the body’s healing process.
comments powered by